| 000 | 04825cam a2200433Ii 4500 | ||
|---|---|---|---|
| 001 | 95448 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112704.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170227s2017 sz a ob 001 0 eng d | ||
| 020 |
_a3319499114 _q(electronic bk.) |
||
| 020 |
_a9783319499116 _q(electronic bk.) |
||
| 020 | _z3319499106 | ||
| 020 |
_z9783319499109 _q(print) |
||
| 040 |
_aN$T _cN$T _dGW5XE _dN$T _dYDX _dEBLCP _dUAB _dOCLCF _dCOO _dAZU _dIOG _dOCLCO _dVT2 _dUPM _dMERER _dESU _dZ5A _dOCLCO _dOCLCQ _dOCLCO _dJBG _dIAD _dOCLCO _dICW _dOCLCO _dICN _dOCLCQ _dOCLCO _dOTZ _dOCLCQ _dOCLCO _dU3W _dOCLCO _dOCLCA _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRC280.P7 _b2017 EB |
|
| 245 | 0 | 0 |
_aImaging and focal therapy of early prostate cancer _cThomas J. Polascik, editor. |
| 250 | _aSecond edition. | ||
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2017 |
|
| 300 |
_a1 recurso en línea _bilustraciones (algunas a color) |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 | _aCurrent clinical urology | |
| 504 | _aIncluye referencias bibliográficas e índice | ||
| 505 | 0 | _aForeword; The Best Is Still to Come ; Preface; Acknowledgements; Contents; Contributors; Part I: Why Focal Therapy?; 1: Evolution in€the€Concept of€Focal Therapy: The€Story of€Breast Cancer and€Prostate Cancer; Introduction; Breast Cancer; Introduction and€Background; Diagnostic and€Imaging; Surgical Treatment for€Breast Cancer; Palpable Lesions; Non-palpable Lesions; Sentinel Lymph Node and€Axillar Dissection; Conclusion; Prostate Cancer; Introduction and€Background; Diagnostic and€Imaging; Focal Therapy Treatment and€Its Evolution; Options of€Focal Therapy; Cryotherapy. | |
| 505 | 8 | _aHigh-Intensity Focused Ultrasound Photodynamic Therapy; Laser Interstitial Thermotherapy; Irreversible Electroporation; Conclusion; References; 2: Targeted Therapy for€Localized Kidney Cancer; Introduction; The Small Renal Mass Dilemma; Renal Biopsy; Role, Indications, and€Contraindications of€Ablative Therapy; Surgical Approach; Patient Preparation; Principles of€Ablation; Cryoablation; Radiofrequency Ablation; Cryoablation Techniques; Laparoscopic Cryoablation; Percutaneous Cryoablation; Oncological Outcomes and€Follow-up; Efficacy of€Cryoablation. | |
| 505 | 8 | _aSalvage Cryoablation in€the€Setting of€Recurrence Following€Primary Cryoablation Efficacy of€Radiofrequency Ablation; Conclusion; References; 3: Focal Therapy for€Prostate Cancer: A€Guide for€Patients; Introduction; Treatment Options for€Prostate Cancer; Traditional Radical Therapies; Active Surveillance; Focal Therapy; Determining if Focal Therapy Is Suitable for€You; Why Consider Focal Therapy?; Cancer Treatment Needs; Biopsy of€the€Prostate; Imaging; Personal Needs; Mindset and€Personality; Summary: Signs that Focal Therapy May Be€a€Good Fit for€You. | |
| 505 | 8 | _aThe Rationale for€Active Surveillance of€Low-Risk Prostate Cancer North American Uptake of€Active Surveillance; The Limitations of€Active Surveillance; Boundary Between€Active Surveillance and€Focal Therapy; Conclusion; References; 5: Focal Therapy and€Active Surveillance in€Europe; Introduction; Active Surveillance in€Europe; Criteria for€Active Surveillance Inclusion; Repeat Prostate Biopsy Under€Active Surveillance; The Role of€Prostate-Specific Antigen and€Serum Biomarkers; Urinary and€Tissue Markers. | |
| 505 | 8 | _aTypes of€Ablative Technology Available for€Focal Therapy What to€Expect During€the€Treatment Process; What to€Expect Immediately After€Treatment; Long-Term Functional and€Oncological Outcomes after€Focal Therapy; Functional Outcomes; Cancer Treatment Outcomes and€Posttreatment Surveillance; Conclusion; Part II: Global Perspective of Active Surveillance and Focal Therapy; 4: Low-Risk Prostate Cancer in€North America: Rationale, Uptake, and€Limitations of€Active Surveillance and€Opportunities for€Focal Therapy; Introduction. | |
| 520 | 3 | _aThis book evaluates the trend to treat low risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. It examines the latest clinical applications of image-guided diagnosis and treatment. | |
| 650 | 7 |
_aPróstata _xCáncer _2embne _0(OCoLC)fst01079483 _0 _9182337 |
|
| 700 | 1 |
_aPolascik, Thomas J., _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-49911-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aSpringer_Medicine_2017 | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95448 _d95448 _x1 |
||